Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease?
A number of gender differences have been documented in the incidence and symptomatology of the second most common age-related neurodegenerative disorder, idiopathic Parkinson's disease (PD). Overall, previous reports suggest a less frequent incidence and a more benign phenotype in women mainly in Western populations, which is thought to be mediated by estrogens in particular in early stages of the disease. Not only motor symptoms seem to underlie gender effects, but also non-motor symptoms such as psychiatric and cognitive impairments, which can often precede motor manifestation. However, reliable results for gender differences in PD in particular of cognitive function and emotion processing, having a major impact on quality of life, are lacking. Moreover, studies investigating gender effects in PD in these areas have revealed highly heterogeneous results. The present review summarizes findings of currently available studies on gender effects on neuropsychological tests covering major cognitive domains, emotion processing as well as quality of life in patients with PD. Overall, the occurrence of cognitive impairment in PD seems to be associated with male gender, though inconsistent results were shown in cognitive screening tests. Regarding emotion recognition, men with PD were found to be less accurate than women with PD at identifying fearful expressions, whereas vice versa results appeared in healthy subjects. Lower quality of life and greater disability were reported by women compared to men with PD, which corresponds with the results in healthy subjects. Several disease-specific mediators as well as the question of a general gender and age-related effect as observed in healthy individuals are discussed. Increased knowledge on possible gender effects in PD would provide an enhanced insight in underlying pathological mechanisms, and has potential implications for the diagnosis and treatment of PD.
Department of Neurology, RWTH Aachen University, Pauwelsstraße 30, Aachen, Germany ; JARA - Translational Brain Medicine, Jülich and Aachen, Germany.
Julia
J
Heller
Department of Neurology, RWTH Aachen University, Pauwelsstraße 30, Aachen, Germany ; JARA - Translational Brain Medicine, Jülich and Aachen, Germany ; Institute of Neuroscience and Medicine (INM-4), Research Center Jülich GmbH, Wilhelm-Johnen-Straße, Jülich, Germany.
Imis
I
Dogan
Department of Neurology, RWTH Aachen University, Pauwelsstraße 30, Aachen, Germany ; JARA - Translational Brain Medicine, Jülich and Aachen, Germany.
Jörg B
JB
Schulz
Department of Neurology, RWTH Aachen University, Pauwelsstraße 30, Aachen, Germany ; JARA - Translational Brain Medicine, Jülich and Aachen, Germany ; Institute of Neuroscience and Medicine (INM-4), Research Center Jülich GmbH, Wilhelm-Johnen-Straße, Jülich, Germany.
Kathrin
K
Reetz
Parkinson’s disease; cognition; emotion; estrogen; gender; quality of life